166 related articles for article (PubMed ID: 37243325)
1. A single administration of FGF2 after renal ischemia-reperfusion injury alleviates post-injury interstitial fibrosis.
Tan X; Tao Q; Yin S; Fu G; Wang C; Xiang F; Hu H; Zhang S; Wang Z; Li D
Nephrol Dial Transplant; 2023 Oct; 38(11):2537-2549. PubMed ID: 37243325
[TBL] [Abstract][Full Text] [Related]
2. Tubular cells produce FGF2 via autophagy after acute kidney injury leading to fibroblast activation and renal fibrosis.
Livingston MJ; Shu S; Fan Y; Li Z; Jiao Q; Yin XM; Venkatachalam MA; Dong Z
Autophagy; 2023 Jan; 19(1):256-277. PubMed ID: 35491858
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 2 protects against renal ischaemia/reperfusion injury by attenuating mitochondrial damage and proinflammatory signalling.
Tan XH; Zheng XM; Yu LX; He J; Zhu HM; Ge XP; Ren XL; Ye FQ; Bellusci S; Xiao J; Li XK; Zhang JS
J Cell Mol Med; 2017 Nov; 21(11):2909-2925. PubMed ID: 28544332
[TBL] [Abstract][Full Text] [Related]
4. A short treatment with resveratrol after a renal ischaemia-reperfusion injury prevents maladaptive repair and long-term chronic kidney disease in rats.
Martínez-Rojas MÁ; Balcázar H; Ponce-Nava MS; González-Soria I; Marquina-Castillo B; Pérez-Villalva R; Bobadilla NA
J Physiol; 2024 Apr; 602(8):1835-1852. PubMed ID: 38529522
[TBL] [Abstract][Full Text] [Related]
5. Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis.
Menshikh A; Scarfe L; Delgado R; Finney C; Zhu Y; Yang H; de Caestecker MP
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1383-F1397. PubMed ID: 31509009
[TBL] [Abstract][Full Text] [Related]
6. Autophagy activates EGR1 via MAPK/ERK to induce FGF2 in renal tubular cells for fibroblast activation and fibrosis during maladaptive kidney repair.
Livingston MJ; Zhang M; Kwon SH; Chen JK; Li H; Manicassamy S; Dong Z
Autophagy; 2024 May; 20(5):1032-1053. PubMed ID: 37978868
[TBL] [Abstract][Full Text] [Related]
7. Chitosan oligosaccharide attenuates acute kidney injury and renal interstitial fibrosis induced by ischemia-reperfusion.
Yin S; Liu J; Zhao X; Dong H; Cao Y; Zhang S; Dong X; Zhang G; Jin S; Shi W; Xiang F; Gong J; Wang Z; Han B; Zhang N; Tan X; Wang Z
Ren Fail; 2023 Dec; 45(1):2238831. PubMed ID: 37482748
[TBL] [Abstract][Full Text] [Related]
8. NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury.
Xie ZY; Dong W; Zhang L; Wang MJ; Xiao ZM; Zhang YH; Shi WX; Huang Y; Yang Y; Li CL; Fu L; Zhao XC; Li RZ; Li ZL; Chen YH; Ye ZM; Liu SX; Dong Z; Liang XL
Acta Pharmacol Sin; 2022 Aug; 43(8):2081-2093. PubMed ID: 34937917
[TBL] [Abstract][Full Text] [Related]
9. Renoprotective effects of laxative linaclotide: Inhibition of acute kidney injury and fibrosis in a rat model of renal ischemia-reperfusion.
Hitaka Y; Isoyama N; Tsuji S; Honda T; Nakayama Y; Yamaguchi M; Nakamura K; Hirata H; Shiraishi K; Asagiri M
Biochem Biophys Res Commun; 2024 May; 709():149709. PubMed ID: 38554603
[TBL] [Abstract][Full Text] [Related]
10. Gremlin1 and TGF-β1 protect kidney tubular epithelial cells from ischemia-reperfusion injury through different pathways.
Gao X; Han L; Yao X; Ma L
Int Urol Nephrol; 2022 Jun; 54(6):1311-1321. PubMed ID: 34633599
[TBL] [Abstract][Full Text] [Related]
11. KLF4 initiates sustained YAP activation to promote renal fibrosis in mice after ischemia-reperfusion kidney injury.
Xu D; Chen PP; Zheng PQ; Yin F; Cheng Q; Zhou ZL; Xie HY; Li JY; Ni JY; Wang YZ; Chen SJ; Zhou L; Wang XX; Liu J; Zhang W; Lu LM
Acta Pharmacol Sin; 2021 Mar; 42(3):436-450. PubMed ID: 32647339
[TBL] [Abstract][Full Text] [Related]
12. CSF-1R inhibition attenuates ischemia-induced renal injury and fibrosis by reducing Ly6C
Deng X; Yang Q; Wang Y; Zhou C; Guo Y; Hu Z; Liao W; Xu G; Zeng R
Int Immunopharmacol; 2020 Nov; 88():106854. PubMed ID: 32771945
[TBL] [Abstract][Full Text] [Related]
13. Tubulovascular protection from protease-activated receptor-1 depletion during AKI-to-CKD transition.
Lok SWY; Yiu WH; Zou Y; Xue R; Li H; Ma J; Chen J; Chan LYY; Lai KN; Tang SCW
Nephrol Dial Transplant; 2023 Sep; 38(10):2232-2247. PubMed ID: 36914214
[TBL] [Abstract][Full Text] [Related]
14. Knockout of Zeb2 ameliorates progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia-reperfusion injury.
Inotani S; Taniguchi Y; Nakamura K; Nishikawa H; Matsumoto T; Horino T; Fujimoto S; Sano S; Yanagita M; Terada Y
Nephrol Dial Transplant; 2022 Feb; 37(3):454-468. PubMed ID: 34724064
[TBL] [Abstract][Full Text] [Related]
15. New mouse model of chronic kidney disease transitioned from ischemic acute kidney injury.
Wei J; Zhang J; Wang L; Jiang S; Fu L; Buggs J; Liu R
Am J Physiol Renal Physiol; 2019 Aug; 317(2):F286-F295. PubMed ID: 31116604
[TBL] [Abstract][Full Text] [Related]
16. The role of podocyte damage in the etiology of ischemia-reperfusion acute kidney injury and post-injury fibrosis.
Chen Y; Lin L; Tao X; Song Y; Cui J; Wan J
BMC Nephrol; 2019 Mar; 20(1):106. PubMed ID: 30922260
[TBL] [Abstract][Full Text] [Related]
17. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
Hu MC; Shi M; Gillings N; Flores B; Takahashi M; Kuro-O M; Moe OW
Kidney Int; 2017 May; 91(5):1104-1114. PubMed ID: 28131398
[TBL] [Abstract][Full Text] [Related]
18. Effects of contralateral nephrectomy timing and ischemic conditions on kidney fibrosis after unilateral kidney ischemia-reperfusion injury.
Zhang J; Shen R; Lin H; Pan J; Feng X; Lin L; Niu D; Hou Y; Su X; Wang C; Wang L; Qiao X
Ren Fail; 2022 Dec; 44(1):1568-1584. PubMed ID: 36154902
[TBL] [Abstract][Full Text] [Related]
19. Effect of NAD+ boosting on kidney ischemia-reperfusion injury.
Morevati M; Egstrand S; Nordholm A; Mace ML; Andersen CB; Salmani R; Olgaard K; Lewin E
PLoS One; 2021; 16(6):e0252554. PubMed ID: 34061900
[TBL] [Abstract][Full Text] [Related]
20. Xanthine oxidase/NADPH oxidase inhibition by hydralazine attenuates acute kidney injury and prevents the transition of acute kidney injury to chronic kidney disease.
Chiang CH; Chen C; Fang SY; Lin SC; Chen JW; Chang TT
Life Sci; 2023 Aug; 327():121863. PubMed ID: 37331504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
